EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates

Lingyan Yu iD, Yuyueyang Qiu, Xiangmin Tong

Cancers · 11.09.2024 · 16 (18) · 3131

DOI: 10.3390/cancers16183131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.09.2024. Verfasst von Lingyan Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou 310053, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cancer is a common and serious malignant tumor of the urinary system. While surgery effectively treats early-stage renal cancer, advanced cases pose a significant challenge due to poor treatment outcomes and chemotherapy resistance. Therefore, there is an urgent need to develop alternative therapeutic strategies. Ferroptosis is a newly defined form of programmed cell death characterized by the accumulation of iron-dependent lipid peroxides, which plays a critical role in tumor progression and drug resistance. Recent studies have shown that ferroptosis is involved in the occurrence and development of renal cancer, and ferroptosis-related genes can induce cell apoptosis and can be used as potential biomarkers for early diagnosis of renal cancer and participate in drug resistance of renal cancer chemotherapy. With the continuous improvement of the mechanism of ferroptosis, drugs targeting ferroptosis for the treatment of renal cancer are emerging in an endless stream. Based on the theoretical basis of the occurrence of ferroptosis, this paper reviewed drug-induced ferroptosis in renal cancer cells from the aspects of herbal medicine, natural compounds, drug resistance mechanisms, and nanomaterials, and delves into the clinical application potential of ferroptosis-related drugs in the treatment of renal cancer.

Schlagwörter

Stichwörter der Autor:innen

clinical trialsferroptosisherbal extract medicinenanomaterialsnatural compoundrenal cancer

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou 310014, China.
  • Department of Biology, Grinnell College, Grinnell, IA 50112, USA.
  • Department of Laboratory Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.

ORCID-Profile: Lingyan Yu

Zitieren

APA

Yu, L., Qiu, Y., & Tong, X. (2024). Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates. Cancers, 16(18), 3131. https://doi.org/10.3390/cancers16183131

Vancouver

Yu L, Qiu Y, Tong X. Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates. Cancers. 2024;16(18):3131. doi:10.3390/cancers16183131

BibTeX
@article{Yu2024,
  author = {Yu, Lingyan and Qiu, Yuyueyang and Tong, Xiangmin},
  title = {Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {18},
  pages = {3131},
  doi = {10.3390/cancers16183131}
}
Kostenlos starten →